GO
Loading...

Epizyme CEO: Cancer genome efforts being embraced

Friday, 12 Jul 2013 | 6:45 PM ET

Epizyme is a fresh health care IPO on the market. Its CEO Robert Gould discusses his company's efforts to beat cancer